Abstract
The aim of this study was to evaluate the effect of increasing epinephrine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anaphylaxis. Four tablet formulations, A, B, C, and D, containing 0%, 6%, 12%, and 24% of epinephrine bitartrate, respectively, and microcrystalline cellulose:low-substituted hydroxypropyl cellulose (9∶1), were prepared by direct compression, at a range of compression forces. Tablet weight variation, content uniformity, hardness, disintegration time, wetting time, and friability were measured for each formulation at each compression force. All 4 tablet formulations at each compression force were within the United States Pharmacopeia (USP) limits for weight variation and content uniformity. A linear increase in compression force resulted in an exponential increase in hardness for all formulations, a linear increase in disintegration and wetting times of A, and an exponential increase in disintegration and wetting times of B, C, and D. At a mean±SD hardness of ≥2.3±0.2 kg, all tablet formulations passed the USP friability test. At a mean±SD hardness of ≤3.1±0.2 kg, all tablet formulations resulted in disintegration and wetting times of <10 seconds and <30 seconds, respectively. Tablets with drug loads from 0% to 24% epinephrine can be formulated with hardness, disintegration times, and wetting times suitable for sublingual administration.
Keywords: sublingual, transmucosal drug delivery, fastdisintegrating tablets, epinephrine, anaphylaxis
Full Text
The Full Text of this article is available as a PDF (249.0 KB).
References
- 1.Birudaraj R, Berner B, Shen S, Li X. Buccal permeation of buspirone: mechanistic studies on transport pathways. J Pharm Sci. 2005;94:70–78. doi: 10.1002/jps.20208. [DOI] [PubMed] [Google Scholar]
- 2.Ishikawa T, Koizumi N, Mukai B, et al. Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules. Chem Pharm Bull (Tokyo) 2001;49:230–232. doi: 10.1248/cpb.49.230. [DOI] [PubMed] [Google Scholar]
- 3.Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol. Obstet Gynecol. 1997;89:340–345. doi: 10.1016/S0029-7844(96)00513-3. [DOI] [PubMed] [Google Scholar]
- 4.Joint Task Force on Practice Parameters; American Academy of Allergy Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115:483–S523. doi: 10.1016/j.jaci.2005.01.010. [DOI] [PubMed] [Google Scholar]
- 5.Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol. 2003;3:313–318. doi: 10.1097/00130832-200308000-00013. [DOI] [PubMed] [Google Scholar]
- 6.Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol. 2006;113:837–844. doi: 10.1016/j.jaci.2004.01.769. [DOI] [PubMed] [Google Scholar]
- 7.Connors KA, Amidon GL, Stella VJ. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists. New York, NY: Wiley-Interscience Publications; 1986. [Google Scholar]
- 8.Simons KJ, Gu X, Simons FER. Sublingual epinephrine administration in humans: a preliminary study. J Allergy Clin Immunol. 2006;113:260–260. doi: 10.1016/j.jaci.2004.01.405. [DOI] [Google Scholar]
- 9.Rawas-Qalaji MM, Simons FE, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol. 2006;117:398–403. doi: 10.1016/j.jaci.2005.12.1310. [DOI] [PubMed] [Google Scholar]
- 10.Allen LV. Rapid-dissolve technology: an interview with Loyd V. Allen. Int J Pharm Technol. 2003;7:449–450. [Google Scholar]
- 11.Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-making and clinical studies. Crit Rev Ther Drug Carrier Syst. 2006;21:433–476. doi: 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10. [DOI] [PubMed] [Google Scholar]
- 12.Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull. 1995;18:1308–1310. doi: 10.1248/bpb.18.1308. [DOI] [PubMed] [Google Scholar]
- 13.Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo) 1996;44:2121–2127. doi: 10.1248/cpb.44.2121. [DOI] [PubMed] [Google Scholar]
- 14.Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm. 1999;25:571–581. doi: 10.1081/DDC-100102211. [DOI] [PubMed] [Google Scholar]
- 15.Ishikawa T, Mukai B, Shiraishi S, et al. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method. Chem Pharm Bull (Tokyo) 2001;49:134–139. doi: 10.1248/cpb.49.134. [DOI] [PubMed] [Google Scholar]
- 16.Rawas-Qalaji MM, Simons FE, Simons KJ. Evaluation of the effect of changing tablet dimensions on the characteristics of fast-disintegrating sublingual epinephrine tablets for the first-aid treatment of anaphylaxis away from health care facilities. AAPS J. 2004;6:Abstract W4179.
- 17.USP/NF . Physical Tests: Uniformity of Dosage Units (905) 26/21 ed. Rockville MD: United States Pharmacopeial Convention Inc; 2003. [Google Scholar]
- 18.USP/NF . Physical Tests: Tablet Friability (1216) 26/21 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 2003. [Google Scholar]
- 19.Marshall K. Compression and consolidation of powdered solids. In: Lachman L, Lieberman HA, Kanig J, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1986. pp. 66–99. [Google Scholar]
- 20.Sugimoto M, Matsubara K, Koida Y, Kobayashi M. The preparation of rapidly disintegrating tablets in the mouth. Pharm Dev Technol. 2001;6:487–493. doi: 10.1081/PDT-120000287. [DOI] [PubMed] [Google Scholar]
- 21.Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 2002;15:295–305. doi: 10.1016/S0928-0987(02)00011-8. [DOI] [PubMed] [Google Scholar]
- 22.USP/NF . Physical Tests: Disintegration (701) 22/17 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 1990. [Google Scholar]
- 23.USP/NF . Official Monographs: Nitroglycerin Tablets. 22/17 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 1990. [Google Scholar]
- 24.Diem K, Lentner C. Scientific Tables. Basle, Switzerland: CibaGeigy Limited; 1971. [Google Scholar]
- 25.Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292:29–41. doi: 10.1016/j.ijpharm.2004.08.019. [DOI] [PubMed] [Google Scholar]
- 26.el-Arini SK, Clas SD. Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer. Pharm Dev Technol. 2002;7:361–371. doi: 10.1081/PDT-120005732. [DOI] [PubMed] [Google Scholar]
- 27.Dor PJ, Fix JA. In vitro determination of disintegration time of quick-dissolve tablets using a new method. Pharm Dev Technol. 2000;5:575–577. doi: 10.1081/PDT-100102041. [DOI] [PubMed] [Google Scholar]
- 28.Hedenus P, Stromme Mattsson M, Niklasson GA, Camber O, Ek R. Characterisation of instantaneous water absorption properties of pharmaceutical excipients. Int J Pharm. 2000;202:141–149. doi: 10.1016/S0378-5173(00)00436-1. [DOI] [PubMed] [Google Scholar]
- 29.Aly A, Semreen M, Qato M. Superdisintegrants for solid dispersion to produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharmaceutical Technology. 2005; January 2: 68–78.